title: 15th Annual Congress of the European Society of Intensive Care Medicine, 29 September-2 October 2002, Barcelona, Spain: clinical research to improve outcome.
authors.affiliation: Intensivist, Critical Care Medicine Division, University of Montreal Hospital, Montreal, Quebec, Canada. marc-jacques.dubois@umontreal.ca
authors.forename: Marc-Jacques
authors.initials: MJ
authors.lastname: Dubois
authors.forename: Colin L
authors.initials: CL
authors.lastname: Verdant
authors.forename: Redouane
authors.initials: R
authors.lastname: Bouali
mesh_terms: D058186:Acute Kidney Injury / Q000628:therapy; D003422:Critical Care / Q000379:methods* / Q000458:organization & administration*; D005060:Europe; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use; D015994:Incidence; D007362:Intensive Care Units / Q000706:statistics & numerical data; D008176:Lung Volume Measurements; D017063:Outcome Assessment, Health Care / Q000379:methods*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011175:Positive-Pressure Respiration / Q000379:methods; D011724:Pyridazines / Q000627:therapeutic use; D017582:Renal Replacement Therapy / Q000379:methods; D018805:Sepsis / Q000453:epidemiology; D000077464:Simendan; D012955:Societies, Medical; D013030:Spain
chemical_list: D006835:Hydrazones; D010726:Phosphodiesterase Inhibitors; D011724:Pyridazines; D000077464:Simendan